SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haddock, G
Right arrow Articles by Woodroofe, M N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddock, G
Right arrow Articles by Woodroofe, M N
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter

G Haddock

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK, Division of Genomic Medicine, School of Medicine & Biomedical Sciences, E-Floor, The Medical School, Beech Hill Road, Sheffield S10 2RX, UK, g.haddock{at}shu.ac.uk

A K Cross

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK, Division of Genomic Medicine, School of Medicine & Biomedical Sciences, E-Floor, The Medical School, Beech Hill Road, Sheffield S10 2RX, UK

J Plumb

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK

J Surr

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK, Division of Genomic Medicine, School of Medicine & Biomedical Sciences, E-Floor, The Medical School, Beech Hill Road, Sheffield S10 2RX, UK

D J Buttle

Division of Genomic Medicine, School of Medicine & Biomedical Sciences, E-Floor, The Medical School, Beech Hill Road, Sheffield S10 2RX, UK

R AD Bunning

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK

M N Woodroofe

Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield S1 1WB, UK

ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) -1, -4 and -5 proteases have been identified in the CNS at the mRNA level. These glutamyl endopeptidases, inhibited by tissue inhibitor of metalloproteinases (TIMP)-3, are key enzymes in the degradation of the aggregating chondroitin sulphate proteoglycans (CSPGs), and may therefore play a role in CNS extracellular matrix (ECM) changes in multiple sclerosis (MS). We have investigated ADAMTS and TIMP-3 expression in normal and MS CNS white matter by real-time RT-PCR, western blotting and immunohistochemistry. We report for the first time the presence of ADAMTS-1, -4 and -5 in normal and MS white matter. Levels of ADAMTS-1 and -5 mRNA were decreased in MS compared to normal tissue, with no significant change in ADAMTS-4 mRNA levels. Protein levels of ADAMTS-4 were significantly higher in MS tissue compared to normal tissue. Immunohistochemical studies demonstrated that ADAMTS-4 was associated predominantly with astrocytes with increased expression within MS lesions. TIMP-3 mRNA was significantly decreased in MS compared to controls. These studies suggest a role for ADAMTS-4 in the pathogenesis of MS. Further studies on the activity of ADAMTS-4 will enable a better understanding of its role in the turnover of the ECM of white matter in MS.

Key Words: ADAMTS • extracellular matrix • multiple sclerosis • TIMP-3

Multiple Sclerosis, Vol. 12, No. 4, 386-396 (2006)
DOI: 10.1191/135248506ms1300oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. E. McCandless, L. Piccio, B. M. Woerner, R. E. Schmidt, J. B. Rubin, A. H. Cross, and R. S. Klein
Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis
Am. J. Pathol., March 1, 2008; 172(3): 799 - 808.
[Abstract] [Full Text] [PDF]



Advertisement